Salma Jabbour, MD, Professor and Vice Chair of Radiation Oncology at Rutgers Cancer Institute, provides an invaluable perspective rooted in her extensive experience and passion for radiation oncology, then she delves into the transformative changes witnessed in radiation oncology over the past two decades, contrasting its trajectory with precision oncology.
She shares compelling insights into the PROSPECT trial’s innovative approach of omitting radiation therapy entirely for rectal cancer patients, emphasizing the “impressive” results unveiled in the study. Then, the New York Times articles characterizing radiation as “brutal” for patients in this context is considered, and Dr. Jabbour navigates the complexities, challenges, and potential paradigm shifts these findings might signal for the field.
Don’t miss this unique episode and as always, please share with others after you hit the subscribe and like buttons. Check out also my book “Toxic Exposure” available everywhere.
N/A
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
